National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ & Nutropin

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02314676` - Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children	Phase 4
Completed	`NCT01187550` - Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®	Phase 4
Completed	`NCT00102258` - Role of Nutrition and Hormones in Boys With Disordered Growth	Phase 2
Completed	`NCT00097526` - Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)	Phase 4

See also

Status

Clinical Trial

Phase

Recruiting

NCT02314676 - Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Phase 4

Completed

NCT01187550 - Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Phase 4

Completed

NCT00102258 - Role of Nutrition and Hormones in Boys With Disordered Growth

Phase 2

Completed

NCT00097526 - Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00097513
Study type	Observational
Source	Genentech, Inc.
Contact
Status	Completed
Phase	Phase 4
Start date	February 2003
Completion date	June 2006

National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms